Filed by Versum Materials, Inc.
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule14a-12
under the Securities Exchange Act of 1934
Subject Company: Versum Materials, Inc.
Commission File No.:1-37664
Date: February 27, 2019
The following is a letter from Versum Materials’ CEO to the employees of Versum Materials distributed on February 27, 2019.
***
Employee Email
Versum Team –
As you may have seen, today we issued a press release announcing that we received a competing offer from Merck KGaA to acquire Versum. We realize this new may raise questions, so I wanted to provide some context around what it means.
Our Board of Directors, in consultation with its independent financial and legal advisors, will thoroughly review the Merck proposal to determine the best course of action for our company and shareholders. We cannot speculate as to what these discussions and the outcome of the Board’s review will bring. Know that our guiding principle is to communicate with you as transparently as possible.
We recognize that this development may be distracting, particularly following our announcement of an agreement to combine in a merger of equals with Entegris. We continue to believe in the strategic and financial rationale of that proposed combination. It is business as usual at Versum, and we should all maintain a strong focus on meeting our financial objectives, executing our strategy, and maintaining a safe work environment.
Thank you for all of your hard work, dedication and commitment to Versum.
Regards,
Guillermo Novo
President & CEO